---
title: "Anakinra - Rheumatoid arthritis"
sidebar: mydoc_sidebar
permalink: db00026-mesh-d001172-1.html
toc: false 
---


Path ID: `DB00026_MESH_D001172_1`
{% include image.html url="images/db00026-mesh-d001172-1.png" file="db00026-mesh-d001172-1.png" alt="db00026-mesh-d001172-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D053590 | Anakinra | Drug |
| UniProt:P14778 | Interleukin-1 receptor type 1 | Protein |
| GO:0004908 | Interleukin-1 receptor activity | MolecularActivity |
| REACT:R-HSA-1592389 | Activation of Matrix Metalloproteinases | Pathway |
| HP:0100773 | Cartilage destruction | PhenotypicFeature |
| MESH:D001172 | Rheumatoid arthritis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Anakinra | DECREASES ACTIVITY OF | Interleukin-1 Receptor Type 1 |
| Interleukin-1 Receptor Type 1 | PARTICIPATES IN | Interleukin-1 Receptor Activity |
| Interleukin-1 Receptor Activity | POSITIVELY REGULATES | Activation Of Matrix Metalloproteinases |
| Activation Of Matrix Metalloproteinases | POSITIVELY REGULATES | Cartilage Destruction |
| Cartilage Destruction | OCCURS IN | Rheumatoid Arthritis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00026#BE0000565](https://go.drugbank.com/drugs/DB00026#BE0000565)
  - [https://pubmed.ncbi.nlm.nih.gov/17027524/](https://pubmed.ncbi.nlm.nih.gov/17027524/)
